Intuitive Surgical stock (NASDAQ: ISRG) shares have increased 18.72% in the last 12 months and shareholders have seen the shares decline by -2.80% since the start of the year.
In spite of the recent upside, the mixed financial performance can be linked to executive leadership changes, analyst sentiments, and insider trading activities paint a complex picture, demanding a closer examination of the company’s prospects and potential challenges.
The past year has been marked by a mixture of positive milestones and emerging concerns for Intuitive Surgical. The company's first-quarter 2025 results, reported in April, showcased impressive financial performance. Revenue surged 19.2% year-over-year to $2.25 billion, driven by a significant increase in da Vinci surgical procedures and an expanding installed base. Non-GAAP earnings per share (EPS) reached $1.81, exceeding analyst expectations by 4.4%.
This strong performance underscores the continued demand for robotic-assisted surgery and Intuitive Surgical's ability to capitalize on this trend. Procedure growth, a key metric for the company, demonstrates the increasing adoption of the da Vinci system across various surgical specialties.
YOUR CAPITAL IS AT RISK
Intuitive Surgical Share Price Targets
Analysts have set a 12-month price target for Intuitive Surgical with an average expectation of $575.49, ranging from a high of $675.00 to a low of $350.00.
The current consensus average target suggests a potential increase of 12.98% from the most recent trading price.
Our View: You would be wise to consider the views of the analyst community in conjunction with the fundamentals surrounding the company to properly determine a value for the stock that you feel is appropriate.
At the upper end of analysts estimates it would be easy to get carried away with the potential gains on show, but the flipside is that these targets can shift within the blink of an eye and that the view of analysts is very dynamic.
If you are considering swing trading, or day trading Intuitive Surgical shares that is a separate consideration, but for those planning for the long haul, fundamental analysis is king.
Intuitive Surgical – The Basics Driving The Business
Intuitive Surgical is a pioneer and global leader in robotic-assisted surgery. The company’s innovative da Vinci surgical system has revolutionized minimally invasive procedures, offering surgeons enhanced precision, dexterity, and control, ultimately leading to improved patient outcomes. As a result, Intuitive Surgical has enjoyed substantial growth and market dominance over the past two decades.
Intuitive Surgical designs, manufactures, and markets the da Vinci surgical systems and related instruments and accessories. These systems enable surgeons to perform complex procedures through small incisions, reducing trauma, blood loss, and recovery time compared to traditional open surgery.
The company’s business model is multifaceted, generating revenue from system sales, recurring instrument and accessory sales (driven by procedure volume), and service contracts. This recurring revenue stream provides a degree of stability and predictability, attractive to investors.
Intuitive Surgical's global presence is significant, with systems installed in hospitals worldwide, although the United States remains its largest market. The company continually invests in research and development to enhance its existing technology and expand its portfolio of surgical applications.
